These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32129901)

  • 21. Tongue tremor in neurofascin-155 IgG4 seropositive chronic inflammatory polyradiculoneuropathy.
    Briani C; Salvalaggio A; Ruiz M; Cacciavillani M; Rinaldi F; Callegari I; Gasparotti R; Franciotta D
    J Neuroimmunol; 2019 May; 330():178-180. PubMed ID: 30713112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restoration of a Conduction Block after the Long-term Treatment of CIDP with Anti-neurofascin 155 Antibodies: Follow-up of a Case over 23 Years.
    Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Atsuta N; Nakamura T; Hirayama M; Ogata H; Yamasaki R; Kira JI; Katsuno M; Sobue G
    Intern Med; 2018 Jul; 57(14):2061-2066. PubMed ID: 29491293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurofascin-140 and -155 antibodies in an atypical case of poems syndrome.
    Rempe T; Ho KWD; Shahid M; Yang LJ; Chuquilin M
    Muscle Nerve; 2019 Jul; 60(1):E1-E3. PubMed ID: 31018253
    [No Abstract]   [Full Text] [Related]  

  • 24. Secondary amyloidosis as a life-ending event in multifocal motor neuropathy.
    Beydoun SR; Rison RA; Commins D
    Muscle Nerve; 2001 Oct; 24(10):1396-402. PubMed ID: 11562923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Miller-Fisher syndrome associated with chronic lymphocytic leukemia.
    Aki Z; Aksoy O; Sucak G; Kuruoğlu R; Yağci M
    Neurol India; 2008; 56(2):198-200. PubMed ID: 18688150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurofascin-155 IgM autoantibodies in patients with inflammatory neuropathies.
    Doppler K; Stengel H; Appeltshauser L; Grosskreutz J; Man Ng JK; Meinl E; Sommer C
    J Neurol Neurosurg Psychiatry; 2018 Nov; 89(11):1145-1151. PubMed ID: 29945879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Multifocal motor neuropathy with partial block of nerve conduction].
    Gutiérrez Ronquillo JH; Andrade Machado R; Machado Rojas A; García Espinosa A
    Rev Neurol; 2001 Mar 1-15; 32(5):427-30. PubMed ID: 11346823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multifocal motor neuropathy presenting as chronic progressive proximal leg weakness.
    Mäurer M; Stoll G; Toyka KV
    Neuromuscul Disord; 2004 Jun; 14(6):380-2. PubMed ID: 15145341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B-cell chronic lymphocytic leukaemia presenting as lower motor neuron disease and SS.
    Papageorgiou A; Tzioufas AG; Voulgarelis M
    Rheumatology (Oxford); 2012 Jul; 51(7):1338-40. PubMed ID: 22389126
    [No Abstract]   [Full Text] [Related]  

  • 30. Neurofascin antibodies in inflammatory neuropathy: how many needles make a haystack?
    Hughes RA; Willison HJ
    Neurology; 2012 Dec; 79(23):2224-5. PubMed ID: 23100403
    [No Abstract]   [Full Text] [Related]  

  • 31. Lymphoproliferative disorders and motor neuron disease.
    Leone KV; Phillips LH
    Neurology; 1998 Feb; 50(2):576. PubMed ID: 9484412
    [No Abstract]   [Full Text] [Related]  

  • 32. Motor neuron disease as a treatment responsive paraneoplastic neurological syndrome in patient with small cell lung cancer, anti-Hu antibodies and limbic encephalitis.
    Cheli M; Dinoto A; Ridolfi M; Sartori A; Stokelj D; Manganotti P
    J Neurol Sci; 2019 May; 400():158-159. PubMed ID: 30953906
    [No Abstract]   [Full Text] [Related]  

  • 33. Polyneuropathies and chronic inflammatory demyelinating polyradiculoneuropathy in multiple sclerosis.
    Suanprasert N; Taylor BV; Klein CJ; Roforth MM; Karam C; Keegan BM; Dyck PJB
    Mult Scler Relat Disord; 2019 May; 30():284-290. PubMed ID: 30870805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-ganglioside antibodies and motor neuropathy in relation to nerve conduction block].
    Kaji R; Nishio T; Bara W; Mesaki T; Matsui H; Akiguchi I; Kimura J
    No To Shinkei; 1992 Aug; 44(8):691-8. PubMed ID: 1419346
    [No Abstract]   [Full Text] [Related]  

  • 35. [Case of pure motor Guillain-Barré syndrome with motor conduction block and anti-GM1/GalNAc-GD1a antibody].
    Ogawa G; Kaida K; Shiozaki Y; Araki M; Kimura F; Kamakura K
    Rinsho Shinkeigaku; 2009 Aug; 49(8):488-92. PubMed ID: 19827599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of low dose rituximab in treatment-resistant CIDP with antibodies against NF-155.
    Jiao L; Xiang Y; Li S; Zhang F; Ruan X; Guo S
    J Neuroimmunol; 2020 Aug; 345():577280. PubMed ID: 32563125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relapsing chronic low-dose corticosteroid-responsive multifocal motor neuropathy with conduction block.
    de Carvalho M; Luís ML
    Electromyogr Clin Neurophysiol; 1997 Mar; 37(2):95-7. PubMed ID: 9098673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bilateral phrenic neuropathy as a presenting feature of multifocal motor neuropathy with conduction block.
    Beydoun SR; Copeland D
    Muscle Nerve; 2000 Apr; 23(4):556-9. PubMed ID: 10716767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute motor conduction block neuropathy Another Guillain-Barré syndrome variant.
    Capasso M; Caporale CM; Pomilio F; Gandolfi P; Lugaresi A; Uncini A
    Neurology; 2003 Sep; 61(5):617-22. PubMed ID: 12963751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute motor conduction block neuropathy followed by axonal degeneration and poor recovery.
    Uncini A; Capasso M
    Neurology; 2006 Aug; 67(3):543; author reply 543. PubMed ID: 16894134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.